Top Markets
#1 EXOD EXOD +9.04%
#2 MarsCoin MarsCoin +7.94%
#3 Solstice Solstice +7.85%
#4 peaq peaq +5.93%
#5 DexNet DexNet +5.76%
#6 Versatize Coin Versatize Coin +5.26%
#7 Official Trump Official Trump +5.10%
#8 aelf aelf +4.67%
#9 Utya Utya +4.66%
#10 Bless Bless +4.34%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Hugel, Inc. Hugel, Inc.

Hugel, Inc.

145020
Classificação em ações #6806
Hugel, Inc. is a biopharmaceutical firm headquartered in Chuncheon-si, South... Hugel, Inc. is a biopharmaceutical firm headquartered in Chuncheon-si, South Korea, with a presence both domestically and internationally. The company specializes in the development and manufacturing of diverse medical solutions. A primary product is its Botulinum Toxin, presented as a clear glass vial containing a white, injectable dry powder. This therapeutic is prescribed for several conditions: treating essential eyelid spasms in adults over 18; ameliorating severe frown lines linked to corrugator and/or procerus muscle activity in adults aged 18 to 65; managing upper limb spasticity following a stroke; and correcting dynamic equinus foot deformity in children with cerebral palsy aged over 2. Furthermore, it aids in improving the lateral canthal lines (crow's feet) caused by orbicularis oculi muscle activity in adults between 19 and 65. This product is marketed under various labels, including Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot. Hugel also provides hyaluronic acid dermal fillers, known as Dermalax and The Chaeum; cosmetic products under the Wellage brand; and medical devices distributed as BlueRose. Hugel, Inc. commenced operations in 2001.
Preço da ação
$170.80
Valor de mercado
$1.85B
Variação (1 dia)
0.61%
Variação (1 ano)
-25.35%
País
KR
Negociar Hugel, Inc. (145020)

Categoria

Healthcare
Histórico de preços das ações de Hugel, Inc. (145020)
Preço de fecho mais alto: $177.76 em 2026-08-01

Preço de fecho mais baixo: $51.58 em 2015-12-01
Histórico de preços das ações da Hugel, Inc. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 14.00%
2025 -16.79%
2024 62.92%
2023 14.44%
2022 -21.30%
2021 -24.64%
2020 58.14%
2019 2.42%
2018 -31.10%
2017 76.88%
2016 66.79%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 39.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 50.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.22 -12.71%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 475.44%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.74%
CH